Balyasny Asset Management’s Spruce Biosciences SPRB Stock Holding History
Bought
Maintained
Sold
Other funds holding SPRB
ACM
Balyasny Asset Management's SPRB Position: Q3 2026 in Review
Balyasny Asset Management held its Spruce Biosciences (SPRB) position steady in Q3 2026 at 12,138 shares worth $590K. The position accounts for ﹤0.01% of the portfolio, ranked #2483.
Balyasny Asset Management first reported a position in SPRB in Q1 2024 and has held it in 5 quarters since. The position peaked at $3.48M in Q4 2025. 70 funds tracked by Wall St. Rank hold SPRB as of Q3 2026.
- Balyasny Asset Management held 12,138 shares of Spruce Biosciences worth $590K as of Q3 2026.
- Balyasny Asset Management left its Spruce Biosciences share count unchanged in Q3 2026.
- Spruce Biosciences made up ﹤0.01% of Balyasny Asset Management's portfolio in Q3 2026, its #2483 holding.
- Balyasny Asset Management first reported a position in Spruce Biosciences in Q1 2024 and has held it in 5 quarters since.
- Balyasny Asset Management's Spruce Biosciences position peaked at $3.48M in Q4 2025.
- 70 funds tracked by Wall St. Rank held Spruce Biosciences as of Q3 2026.
Based on Balyasny Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.